Effects of a Widely Used Vaccine Adjuvant in Subjects With Early Alzheimer's Disease Double-blind Study to Assess the Safety and Efficacy of AD04 in Patients With Early Alzheimer's Disease - ADVANCE
Clinical trial NCT07107074 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07107074
- Sponsor
- ADvantage Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-08
- Primary completion
- 2026-12-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.